phenylacetohydroximoyl chloride | 701-72-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: phenylacetohydroximoyl chloride
• 英文别名: N-hydroxy-2-phenylacetimidoyl chloride；Phenylacetohydroximoyl chloride；N-hydroxy-2-phenylethanimidoyl chloride
• CAS: 701-72-4
• 化学式: C₈H₈ClNO
• 分子量: 169.611
• InChiKey: GZBWRHWHHPBVHE-UHFFFAOYSA-N

物化性质

• 沸点：
  306.2±35.0 °C(Predicted)
• 密度：
  1.17±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.6
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.12
• 拓扑面积：
  32.6
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  phenylacetohydroximoyl chloride 在 氢氧化钾 、 三乙胺 作用下， 以 甲醇 为溶剂， 反应 18.0h， 生成 苄脲
  参考文献：
  名称：

  Chow, Yuan L.; Polo, Joel S., Journal of the Chemical Society. Perkin transactions II, 1986, p. 727 - 734

  摘要：

  DOI：
• 作为产物：
  描述：

  Β-硝基苯乙烷 在 sodium methylate 、 氯化亚砜 作用下， 以 甲醇 、 乙二醇二甲醚 为溶剂， 以45%的产率得到phenylacetohydroximoyl chloride
  参考文献：
  名称：

  Synthesis and anti-inflammatory activity of aromatic glucosinolates

  摘要：

  Aromatic GLs are important members of the glucosinolate family of compounds because of their potential biological activity and medicinal properties. This study has shown success in the high yielding synthesis of some important aromatic GLs as well as the results of testing for anti-inflammatory properties of the synthetic GLs. 3,4-Dimethoxyphenylglucosinolate was found to be the most active anti-inflammatory of the seven glucosinolates assayed. (C) 2013 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2013.07.049

文献信息

• SYNTHESIS OF THIOHYDROXIMATES THE ADDITION OF THIOLS TO NITRILE OXIDES
  作者：M. H. Benn

  DOI：10.1139/v64-352

  日期：1964.11.1

  The addition of thiols to nitrile oxides is shown to constitute a general synthesis of thiohydroximates.

  向腈氧化物添加硫醇被证明构成了硫代羟基肟酸盐的一般合成。
• [EN] PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND MEDICAL USES THEREOF<br/>[FR] COMPOSÉS À BASE DE PYRIDINONE ET DE PYRIDAZINONE ET UTILISATIONS MÉDICALES ASSOCIÉES
  申请人：HLA TIMOTHY

  公开号：WO2019173790A1

  公开（公告）日：2019-09-12

  The various examples presented herein are directed to compounds of the formula A-L1-Het1-L2-Cy1 or a pharmaceutical acceptable salt, polymorph, prodrug, solvate or clathrate thereof, wherein: A is cycloalkyl, aryl, arylalkyl or heterocyclyl; Het1 is heterocyclyl containing at least two heteroatoms; Cy1 is a heterocyclyl; L1 is a bond, alkyl, alkenyl or alkynyl linker; L2 is an acyl or alkyl linker; and A and Cy1 are different. The compounds are useful in the treatment of fibrotic diseases, abnormal vascular leak and pathological angiogenesis.

  本文提供的各种示例涉及到以下公式的化合物A-L1-Het1-L2-Cy1或其药用可接受的盐、多型体、前药、溶剂合物或包合物，其中：A为环烷基、芳基、芳基烷基或杂环烷基；Het1为含有至少两个杂原子的杂环烷基；Cy1为杂环烷基；L1为键、烷基、烯基或炔基连接物；L2为酰基或烷基连接物；A和Cy1不同。这些化合物在治疗纤维化疾病、异常血管渗漏和病理性血管生成方面具有用途。
• [EN] IMIDAZOPYRROLOPYRIDINE AS INHIBITORS OF THE JAK FAMILY OF KINASES<br/>[FR] IMIDAZOPYRROLOPYRIDINE EN TANT QU'INHIBITEURS DE LA FAMILLE JAK DE KINASES
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2018112382A1

  公开（公告）日：2018-06-21

  2-((1r,4r)-4-(imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)cyclohexyl)acetonitrile compounds, pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions mediated by JAK, such as inflammatory bowel disease.

  2-((1r,4r)-4-(imidazo[4,5-d]pyrrolo[2,3-b]pyridin-1(6H)-yl)cyclohexyl)acetonitrile化合物，含有它们的药物组合物，制备它们的方法，以及使用它们的方法，包括用于治疗由JAK介导的疾病状态、紊乱和疾病，如炎症性肠病的方法。
• Design, Synthesis, and Structure-Activity Relationships of 3,4,5-Trisubstituted 4,5-Dihydro-1,2,4-oxadiazoles as TGR5 Agonists
  作者：Junjie Zhu、Yangliang Ye、Mengmeng Ning、Attila Mándi、Ying Feng、Qingan Zou、Tibor Kurtán、Ying Leng、Jianhua Shen

  DOI：10.1002/cmdc.201300144

  日期：2013.7

  By thorough analysis of diverse structures of published TGR5 agonists, a hypothetical ligand‐based pharmacophore model was built, and a new class of potent TGR5 agonists, based on the novel 3,4,5‐trisubstituted 4,5‐dihydro‐1,2,4‐oxadiazole core, was discovered by rational design. Three distinct synthetic methods for constructing 4,5‐dihydro‐1,2,4‐oxadiazoles and extensive structure–activity relationship

  鉴于其在能量和葡萄糖稳态中的介导作用，G蛋白偶联胆汁酸受体1（TGR5）被认为是治疗2型糖尿病和其他代谢性疾病的潜在靶标。通过对已发表的TGR5激动剂的各种结构进行全面分析，建立了一个假设的基于配体的药效团模型，并基于新型3,4,5-三取代的4,5-二氢-1，2来开发了一类新型的强效TGR5激动剂。 ，4-恶二唑核是通过合理设计发现的。本文报道了三种不同的合成方法来构建4,5-二氢-1,2,4-恶二唑和广泛的结构-活性关系研究。化合物（R）-54 n，其结构是通过单晶X-射线衍射和量子化学固态TDDFT-ECD计算确定，显示出最好的效力，用EC 50为1.4的n值中号朝向hTGR5。它在体外的有利特性值得进一步研究。
• The mild oxidation of nitrile oxides affords a convenient entry to nitrosocarbonyl intermediates, versatile tools in organic syntheses
  作者：P. Quadrelli、M. Mella、A. Gamba Invernizzi、P. Caramella

  DOI：10.1016/s0040-4020(99)00574-8

  日期：1999.8

  Nitrile oxides are oxidized by tertiary amine N-oxides in different solvents at room temperature to afford in the presence of dienes nitrosocarbonyl adducts in fair yields. The mild conditions used in oxidizing a variety of nitrile oxides promise a wide application of this method in synthetic processes.

  在室温下，在不同的溶剂中，叔丁胺N-氧化物将腈氧化物氧化，在二烯亚硝基羰基加合物的存在下以合理的收率提供。用于氧化多种腈氧化物的温和条件使该方法在合成过程中得到广泛应用。